“Bogotá Your Home”: A Showcase of Bogotá’s New Image at COP16
BOGOTÁ, COLOMBIA / ACCESSWIRE / October 29, 2024 / "Bogotá tu casa" - "Bogotá Your Home", a campaign led by the District Institute of Tourism in collaboration with the Bogotá Chamber of Commerce and Invest in Bogotá, was showcased at COP16 to hundreds of visitors. The campaign highlighted the capital's key attributes and opportunities for tourists, entrepreneurs, and investors.
"As Invest in Bogotá, we supported this activation to show the world why Bogotá is a city full of opportunities for businesspeople, investors, and global-scale events. We look forward to guiding international decision-makers in exploring the city's investment opportunities as a platform for business expansion and growth", said Isabella Muñoz.
"Bogotá Your Home," the new campaign by the Bogotá District Institute of Tourism, the Bogotá Chamber of Commerce, and Invest in Bogotá, was promoted at COP16.
The event took place at the House of Bogotá and the Bogotá Chamber of Commerce at Bulevar del Río in Cali, the host city for the world's largest biodiversity summit. Attendees enjoyed an urban music show, a large-scale graffiti installation inspired by Bogotá's landscapes and ecosystems, and other activities.
"We are here proudly representing Bogotá, showcasing a city of opportunities that welcomes both locals and visitors. We strive to make Bogotá even greater because it deserves more", stated Ovidio Claros Polanco, Executive President of the Bogotá Chamber of Commerce.
The event also featured a digital photography exhibition titled "Bogotá, a Biodiverse Destination", which presented 16 of the capital's key green and conservation sites, such as wetlands, trails, viewpoints, and the stunning Sumapaz paramo.
The exhibition aimed to encourage visitors to discover these natural treasures, serving as both a visual portfolio and a tourist guide to explore Bogotá's biodiversity and its balance between urban and natural environments.
The campaign "Bogotá Your Home" seeks to captivate and inspire both locals and visitors, building trust and emotional connections. It is the result of a well-coordinated effort between the Mayor's Office of Bogotá, the Bogotá Chamber of Commerce, and Invest in Bogotá, institutions committed to the city's development and competitiveness. [Watch the official campaign video here.]
"Bogotá Your Home at COP16 exemplifies how coordinated tourism efforts between the Chamber of Commerce and Invest in Bogotá can strengthen the city's competitiveness and development", emphasized Andrés Santamaría, director of the District Institute of Tourism (IDT).
One of the most significant milestones of this campaign will take place on November 4th in New York City, when the campaign will light up the screens of Times Square to evoke emotions, build trust, and spark the interest of potential tourists, entrepreneurs, and investors, especially from the North American market.
"Path to Biodiversity Compliance from a Local Perspective"
During the weekend, the city's investment promotion agency also participated in several activities, including the panel discussion "Path to Biodiversity Compliance from a Local Perspective." This panel provided a space for exchanging experiences with local and regional stakeholders on developing tools and implementing actions to meet national and international biodiversity conservation goals.
Invest in Bogotá participated in the panel "Path to Biodiversity Compliance from a Local Perspective" at COP16.
Bogotá has already begun implementing an integrated strategy across land, air, and water to reduce pollution. This strategy includes restoring the eastern hills, participatory and efficient management of the city's main ecological structure, improving environmental quality-particularly in the city's southwest-and comprehensive watershed management, among other initiatives.
However, Mayor Carlos Fernando Galán called for greater inclusion of local administrations in these discussions: "It is essential that subnational governments have a voice that is heard. We possess the tools and the highest capacity to act in our territories. However, since we are not part of the negotiation stage, our voices often go unheard", he acknowledged.
Later, Invest in Bogotá participated in the CAF's (Andean Development Corporation) joint commitment to sustainable cities and biodiversity, where cities like Bogotá and Santa Marta prioritized nature conservation. The event also included the First Meeting of the Mayors' Forum on Urban Nature and Biodiversity, a space where cities reaffirmed their commitment to urban nature and biodiversity and called for increased funding for these efforts.
Signing of the Capital Cities Commitment -#BiodiverCities- to further integrate biodiversity into planning and sustainable development.
COP16 aims to establish agendas, commitments, and frameworks for conserving biological diversity, promoting sustainable use, and ensuring fair and equitable sharing of the benefits derived from genetic resources. The summit will conclude its agenda in Cali on November 1st.
Contact information
Phone number: (+57) 317 780 6158
Email: info@investinbogota.org
SOURCE: Invest in Bogota
View the original press release on accesswire.com
Invest in Bogota
Subscribe to releases from ACCESSWIRE
Subscribe to all the latest releases from ACCESSWIRE by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESSWIRE
Dr. Falk Pharma Acquires Kynos Therapeutics, Adding Acute Pancreatitis as a Therapeutic Focus and Further Strengthening Its Development Portfolio29.10.2024 08:00:00 CET | Press release
FREIBURG, GERMANY / ACCESSWIRE / October 29, 2024 / Today, Dr. Falk Pharma GmbH announces the successful acquisition of Kynos Therapeutics Ltd., a clinical stage biopharmaceutical company focusing on the development of novel treatments for patients suffering from acute and chronic inflammatory diseases. The company was founded as a spin-out of the University of Edinburgh, Scotland, together with lead investor Epidarex Capital, a leading early-stage transatlantic venture fund, along with IP Group, and Scottish Enterprise. Effective immediately, Kynos Therapeutics will be integrated into the Falk Group. Dr. Falk Pharma Dr. Falk Pharma Logo Kynos Therapeutics' lead investigational asset is KNS366, a highly potent and selective first-in-class inhibitor of the enzyme kynurenine 3-monooxygenase (KMO). In a Phase I clinical trial, KNS366 was shown to be safe and well-tolerated at multiple doses. The compound also led to a dose-dependent inhibition of the enzyme KMO and modulation of its downs
Polaris Renewable Energy Announces Acquisition Transaction in Puerto Rico29.10.2024 07:50:00 CET | Press release
TORONTO, ON / ACCESSWIRE / October 29, 2024 / Polaris Renewable Energy Inc. (TSX:PIF) ("Polaris" or the "Company"), is pleased to announce that it has entered into an Equity Capital Contribution Agreement ("ECCA") with respect to Punta Lima Wind Farm LLC (a wholly owned subsidiary of Santander Bank N.A. -"Santander"-). The project is an operating onshore wind farm called Punta Lima Wind Farm ("PLWF" or the "Project") with a nameplate capacity of 26.0 MW's located in the Municipality of Naguabo, Puerto Rico. The Project was re-constructed and recommissioned by Santander and has a 20-year power purchase agreement ("PPA") in place with Puerto Rico Electric Power Authority (PREPA) terminating in March 2044. The transaction is being completed using a tax-equity structure which will result in Polaris becoming the manager and operator of the Project with a controlling equity interest and Santander retaining a tax equity interest in the Project. the transaction is subject to customary closing
BioNxt Announces National Level Patent Filings for Sublingual Anticancer Drugs for the Treatment of Autoimmune Neurodegenerative Diseases29.10.2024 03:05:00 CET | Press release
VANCOUVER, BC / ACCESSWIRE / October 29, 2024 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT) is pleased to announce that it has initiated the nationalization process for the filing of a family of patents for the sublingual delivery of anticancer drugs for the treatment of autoimmune neurodegenerative diseases. The patents are 100% owned by BioNxt. Subject to the international Patent Cooperation Treaty ("PCT"), the European Patent Office ("EPO") issued a positive International Preliminary Report on Patentability ("IPRP"), announced by the Company on September 9, 2024. The EPO accepted the Company's claim that the patent family was new, useful, and non-obvious, satisfying the requirements for patentability. Based on the report's findings, BioNxt is advancing its patent protection process to national level filings in the following international jurisdictions: Independent filing nations: Australia (AU), Canada (CA), New Zealand (NZ), USA (US), Japan
New CEO Commits to Strengthening OMP’s Leadership in Advanced Supply Chain Planning29.10.2024 02:00:00 CET | Press release
ANTWERPEN, BELGIUM / ACCESSWIRE / October 29, 2024 / In a leadership transition at the Antwerp-based supply chain specialists, Anita Van Looveren will step into her new role as Chairwoman of the Board of Directors on November 1, after nearly 25 years in the CEO role and almost 40 years with the company. Paul Vanvuchelen, Global Delivery Lead, will succeed her as CEO, beginning a new chapter for OMP with a focus on strengthening its leadership in advanced supply chain planning. In her new position, Anita Van Looveren will continue to work closely with Paul Vanvuchelen, offering strategic guidance and support. Anita Van Looveren and Paul Vanvuchelen Under the stewardship of company founder Georges Schepens and long-time CEO Anita Van Looveren, OMP has grown into a global leader inadvanced supply chain planning. Since its inception in 1985, OMP has built a strong reputation by working with an expanding portfolio of customers, including innovative startups and blue-chip giants. OMP has hel
Opti Digital Breaks Down the Biggest AdTech Trends in 202528.10.2024 18:39:00 CET | Press release
As the ad tech landscape evolves, 2025 promises to be a pivotal year for digital advertising, with key trends already emerging. BARCELONA, SPAIN / ACCESSWIRE / October 28, 2024 / Magali Quentel-Reme, CEO of Opti Digital; Mohsin Pervez, Senior Director of Platform Solutions and Operations, EMEA at PubMatic; and Langdon Miller, Director of Programmatic at Brainly, share their insights on the future of the AdTech landscape and the key trends set to shape programmatic in 2025. Addressability Solution With over 50% of third-party cookies already phased out and Google's pivotal July 2024 announcement granting users control over cookie settings, the need for effective alternatives is more critical than ever. Langdon Miller, Director of Programmatic at Brainly, explains that " the integration of probabilistic and deterministic IDs, first-party data, contextual segmentation, and bid decoration has led to sustained performance and increased yield. " This is echoed on the buy side, with a growing
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom